ArticleGels (Basel, Switzerland)2026
Development, Characterization, and In Vitro Hemostatic Assessment of an Alginate-Based Wound Dressing Incorporating Liposomal Curcumin.
Article in Gels (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Exuding wounds require dressings that combine effective exudate management, hemostatic activity, and bioactive therapeutic effects. Curcumin possesses antioxidant and anti-inflammatory properties, but its clinical application is limited by poor bioavailability and uncertain effects on coagulation. This study aimed to develop an alginate-based dressing incorporating liposomal curcumin and evaluate its physicochemical and in vitro hemostatic properties. Alginate dressings containing 0-0.5% liposomal curcumin were prepared and characterized. The selected 0.2% liposomal curcumin (D_0.2) formulations were evaluated for swelling behavior, dimensional stability, water vapor transmission rate, optical properties, calcium and polyphenol release, prothrombin time, fibrin morphology, and fibrin secondary structure in simulated serous, inflammatory, and infected wound exudates. D_0.2 exhibited favorable macroscopic integrity and flexibility, enhanced swelling capacity, improved exudate management, and favorable moisture-vapor permeability. The dressing showed controlled release of Ca
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.